"Fas-ten" your seat belt: anti-apoptotic treatment in heart failure takes off.
von Harsdorf
Rüdiger
R
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000517:prevention & control; D061945:Caspase Inhibitors; D020169:Caspases / Q000502:physiology; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D053222:Fas Ligand Protein; D006097:Granulation Tissue / Q000378:metabolism / Q000473:pathology*; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology / Q000517:prevention & control; D006801:Humans; D008562:Membrane Glycoproteins / Q000502:physiology*; D051379:Mice; D008822:Mice, Transgenic; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000473:pathology*; D020257:Ventricular Remodeling / Q000187:drug effects; D019014:fas Receptor / Q000502:physiology*
D061945:Caspase Inhibitors; D015853:Cysteine Proteinase Inhibitors; C505661:FASLG protein, human; D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; D008562:Membrane Glycoproteins; D019014:fas Receptor; D020169:Caspases